| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/19/2001 | US6248513 In vitro detection of infection of cells by microorganism; incubate immunoglobulins with cells and detect the formation of protein immunoglobulin complexes |
| 06/19/2001 | CA2022539C Albumin derivatives with therapeutic functions |
| 06/19/2001 | CA2003307C Streptolysin o antigen derivative, its production and uses |
| 06/14/2001 | WO2001042465A2 Chordin-like molecules and uses thereof |
| 06/14/2001 | WO2001042423A2 Compositions and methods for detecting stress-inducible proteins |
| 06/14/2001 | WO2001042306A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042270A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041741A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 06/14/2001 | WO2001030811A3 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 06/14/2001 | US20010003650 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries |
| 06/14/2001 | CA2393763A1 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 06/14/2001 | CA2393730A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393589A1 Compositions and methods for detecting stress-inducible proteins |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2392764A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 06/13/2001 | EP1106690A2 Polynucleotide encoding autoantigens associated with endometriosis |
| 06/13/2001 | EP1105508A1 Method for purifying proteins and biomolecule or protein complexes |
| 06/13/2001 | EP1105488A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/13/2001 | EP1105487A1 Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 06/13/2001 | EP1105479A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 06/13/2001 | EP1105477A1 Dcr5, a bmp-binding protein, and applications thereof |
| 06/13/2001 | EP1105158A1 Synthetic peptide immunogens and antibodies thereto |
| 06/13/2001 | EP1105157A1 Protein delivery system using human papillomavirus virus-like particles |
| 06/13/2001 | EP0789776B1 Nucleic acid transfer system |
| 06/13/2001 | DE19957838A1 Gentherapie von HIV-Infizierten durch Expression von Membran-verankerten gp41-Peptiden Gene therapy of HIV-infected individuals by expression of membrane-anchored gp41 peptides |
| 06/13/2001 | CN1299410A CD 19XCD2 specific polypeptides and uses thereof |
| 06/12/2001 | US6245895 Antigen/antibody specificity exchanger |
| 06/12/2001 | US6245885 Bax-mediated apoptosis modulating reagents and methods |
| 06/12/2001 | US6245531 Polynucleotide encoding insect ecdysone receptor |
| 06/12/2001 | CA2117477C Multivalent single chain antibodies |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040305A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | WO2001040276A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 06/07/2001 | WO2001040257A2 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | CA2709291A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2496312A1 Colon tumour marker pro4799 polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2494705A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2492070A1 Lung tumor marker pro4329 polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2492049A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491610A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491433A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491258A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2490909A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2490853A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2392946A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2389262A1 Modified il-12 subunits and nucleic acids encoding them |
| 06/06/2001 | EP1104482A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 06/06/2001 | EP1104310A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 06/06/2001 | EP1104304A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298446A Vaccines containing recombinant pilin against i cneisseria gonorrhoeae (or i cneisseria meningitidis) |
| 06/05/2001 | US6242667 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems |
| 06/05/2001 | US6242586 Amino acid sequence of t cell surface antigen; fusion proteins; treatment of autoimmune diseases; antiarthritic agents; antiinflammatory agents; immunosuppressants; diagnosis; recombinant production |
| 06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/05/2001 | US6242236 Generating hydrolytic enzyme by selecting catalytic domain sequence, inserting into cell so that sequence can undergo immunoglobulin superfamily diversification, culturing cell or progeny, identifying enzymes having desired activity |
| 06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
| 06/05/2001 | US6242183 Interaction trap systems for detecting protein interactions |
| 06/05/2001 | CA2168429C Expression of fusion polypeptides transported out of cytoplasm without leader sequences |
| 06/04/2001 | WO2001042474A2 Interferon-like molecules and uses thereof |
| 06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
| 06/03/2001 | CA2325169A1 Somatostatins and method |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038547A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | WO2001038358A2 Hbv/hcv virus-like particle |
| 05/31/2001 | WO2001038355A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 05/31/2001 | WO2001038348A2 G-protein coupled receptor htogh35 |
| 05/31/2001 | WO2001037881A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | WO2001037861A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 05/31/2001 | WO2001009186A3 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 05/31/2001 | WO2000068416A3 Method for localising proteases which split substrates that are specifically connected by a membrane |
| 05/31/2001 | WO2000015758A3 Plant resistance to insect pests mediated by viral proteins |
| 05/31/2001 | WO1999028462A9 Polypeptides and nucleic acids encoding the same |
| 05/31/2001 | CA2392639A1 G-protein coupled receptor htogh35 |
| 05/31/2001 | CA2392527A1 Hbv/hcv virus-like particle |
| 05/31/2001 | CA2392490A1 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | CA2392468A1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | CA2392175A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 05/31/2001 | CA2392019A1 Method of forming a peptide-receptor complex with zsig33 |
| 05/30/2001 | EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 05/30/2001 | EP1102977A1 Fluorescence assay for biological systems |
| 05/30/2001 | EP1102976A1 Multiple frequency fluorescence lifetime imaging |
| 05/30/2001 | EP1102848A2 Molecules designated ldcam |
| 05/30/2001 | EP1102846A1 Pancreatic and ovarian polypeptide, zsig58 |
| 05/30/2001 | EP1102791A1 Modified green fluorescent protein |
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |
| 05/30/2001 | EP0662093B1 Hiv immunotherapeutics |
| 05/30/2001 | CN1297480A Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 05/30/2001 | CN1297452A Modified factor VIII |
| 05/30/2001 | CN1296953A Mycoplasma hyopnaumoniae (mhp) 3 gene nuclein and protein, and use thereof |